Apr 18, 2025
Next Week: Regulatory and Reimbursement Pathways for Digital Therapeutics in Europe
ATA
Exploring Regulatory and Reimbursement Pathways for Digital Therapeutics: Europe
Wednesday, April 23rd, 2025 | 9:00 AM ET
|
As announced recently, ATA Action has acquired the Digital Therapeutics Alliance (DTA), marking the start of an exciting new chapter. This transition unites our collective expertise to enhance policy and advocacy efforts for digital therapeutics (DTx) and the broader digital health ecosystem.
This webinar is the final installment in our series on regulatory and reimbursement pathways for DTx worldwide. Moving forward, we will continue to deliver valuable events and resources focused on DTx and the rapidly evolving digital health landscape.
|
WHAT
In this webinar, speakers will provide a comprehensive overview of the regulatory and reimbursement pathways for DTx in Europe. We will review frameworks in countries including France, Germany, and the United Kingdom.
Join us to hear from our experts who have navigated these pathways, gaining valuable insights from their experiences and strategies, and answering questions including:
- What are the regulatory pathways?
- What are the reimbursement pathways?
- How is the reimbursement pathway impacted by the regulatory pathway?
- How successful are companies in each pathway to date?
- What does a company need to do to be successful in each pathway?
- How do we see the pathways evolving in the next 5 years?
|